May 11, 1998 Ligand Pharmaceuticals Incorporated 10275 Science Center Drive San Diego, CA 92121 Ladies and Gentlemen: The undersigned is a stockholder of Seragen, Inc., a Delaware corporation ("Seragen"). The undersigned understands that Seragen,...Merger Agreement • May 22nd, 1998 • Lilly Eli & Co • Pharmaceutical preparations
The undersigned is a stockholder of Seragen, Inc., a Delaware corporation ("Seragen"). The undersigned understands that Seragen, Ligand Pharmaceuticals Incorporated, a Delaware corporation ("Ligand"), and Knight Acquisition Corporation, a Delaware Corporation ("Merger Sub"), have entered into an Agreement and Plan of Reorganization, dated as of May 11, 1998 (the "Reorganization Agreement"), which provides for the merger (the "Merger") of Merger Sub into Seragen. The undersigned also understands that Ligand, at its option, may provide some or all of the Merger Consideration (as defined in the Reorganization Agreemnt) in the form of shares of voting common stock, par value $.001 per share, of Ligand (the "Common Stock"). The undersigned further understands that the issuance of the Common Stock pursuant to the terms of the Merger will be the subject of a registration statement under the Securities Act of 1933, as amended (the "Registration Statement"), which will be filed with the Securit
AMENDMENT NO. 3 TO OPTION AND WHOLESALE PURCHASE AGREEMENT This Amendment is executed as of the 11th day of May, 1998 by and between Eli Lilly and Company ("Lilly") and Ligand Pharmaceuticals Incorporated ("Ligand"). WHEREAS, Lilly and Ligand have...Option and Wholesale Purchase Agreement • May 22nd, 1998 • Lilly Eli & Co • Pharmaceutical preparations
